CLINICAL_TRIALS
trial_result
· 2019-09-12
Clinical Trial Update: Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet [Phase 4]
Summary
Phase 4 trial comparing patient preference between conventional oral olanzapine tablets and olanzapine orodispersible tablets in schizophrenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED